Literature DB >> 8929370

Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995.

P J van der Maas1, G van der Wal, I Haverkate, C L de Graaff, J G Kester, B D Onwuteaka-Philipsen, A van der Heide, J M Bosma, D L Willems.   

Abstract

BACKGROUND: In 1991 a new procedure for reporting physician-assisted deaths was introduced in the Netherlands that led to a tripling in the number of reported cases. In 1995, as part of an evaluation of this procedure, a nationwide study of euthanasia and other medical practices concerning the end of life was begun that was identical to a study conducted in 1990.
METHODS: We conducted two studies, the first involving interviews with 405 physicians (general practitioners, nursing home physicians, and clinical specialists) and the second involving questionnaires mailed to the physicians attending 6060 deaths that were identified from death certificates. The response rates were 89 percent and 77 percent, respectively.
RESULTS: Among the deaths studied, 2.3 percent of those in the interview study and 2.4 percent of those in the death-certificate study were estimated to have resulted from euthanasia, and 0.4 percent and 0.2 percent, respectively, resulted from physician-assisted suicide. In 0.7 percent of cases, life was ended without the explicit, concurrent request of the patient. Pain and symptoms were alleviated with doses of opioids that may have shortened life in 14.7 to 19.1 percent of cases, and decisions to withhold or withdraw life-prolonging treatment were made in 20.2 percent. Euthanasia seems to have increased in incidence since 1990, and ending of life without the patient's explicit request to have decreased slightly. For each type of medical decision except those in which life-prolonging treatment was withheld or withdrawn, cancer was the most frequently reported diagnosis.
CONCLUSIONS: Since the notification procedure was introduced, end-of-life decision making in the Netherlands has changed only slightly, in an anticipated direction. Close monitoring of such decisions is possible, and we found no signs of an unacceptable increase in the number of decisions or of less careful decision making.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  1996        PMID: 8929370     DOI: 10.1056/NEJM199611283352227

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  57 in total

1.  Dutch euthanasia: could it happen here?

Authors:  J B Vander Veer
Journal:  West J Med       Date:  1999-10

Review 2.  Drugs used in physician-assisted death.

Authors:  D L Willems; J H Groenewoud; G van der Wal
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

3.  A message from holland

Authors: 
Journal:  BMJ       Date:  2000-06-17

4.  Euthanasia and palliative care: reflections from The Netherlands and the UK.

Authors:  Z Zylicz; I G Finlay
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

5.  Hospice and euthanasia in The Netherlands: an ethical point of view.

Authors:  R J Janssens; H A ten Have; Z Zylicz
Journal:  J Med Ethics       Date:  1999-10       Impact factor: 2.903

6.  Refused and granted requests for euthanasia and assisted suicide in the Netherlands: interview study with structured questionnaire.

Authors:  I Haverkate; B D Onwuteaka-Philipsen; A van Der Heide; P J Kostense; G van Der Wal; P J van Der Maas
Journal:  BMJ       Date:  2000-10-07

7.  End-of-life decisions in a developmental center: a retrospective study.

Authors:  Ghan-Shyam Lohiya; Lilia Tan-Figueroa; Hugh Kohler
Journal:  West J Med       Date:  2002-01

8.  The view of religions toward euthanasia and extraordinary treatments in Japan.

Authors:  N Tanida
Journal:  J Relig Health       Date:  2000

9.  Euthanasia: where the Netherlands leads will the world follow? No. Legalisation is a diversion from improving care for the dying.

Authors:  E J Emanuel
Journal:  BMJ       Date:  2001-06-09

10.  Euthanasia: do we know it and do we need it?

Authors:  Bernhard C Pestalozzi
Journal:  Support Care Cancer       Date:  2002-04-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.